Determination of free apolipoprotein(a) in serum by immunoassay and its significance for risk assessment in patients with coronary artery disease

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 1, 1999, Pages 21-28

  Herrmann, Wolfgang ^a   Quast, Sabine ^a   Wolter, Kai ^b   Eger, Hartmut ^b   Kießig, Stefan T ^b   Hahmann, Harry ^c   Kreuter, Jörg ^d   Molinari, Ewald ^e  

^a Zentrallabor der U   (Germany)

^b Immuno GmbH   (Germany)

^c Klinik Schwabenland   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Apolipoprotein(a); Atherosclerosis; Coronary artery disease; Lipoprotein(a)

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; LIPOPROTEIN A; PEPTIDE; SEPHAROSE;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; AMINO ACID SEQUENCE; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEVICE; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNODIFFUSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR;

EID: 0033010102     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.003     Document Type: Article

References (50)

1. Berg K. A new serum type system in man - the Lp system. Acta Pathol Micribiol Scand 1963; 59:369-82.
2. Dahlen G, Ericson C, Furberg C, Lundkvist L, Svardsudd K. Studies on an extra pre-beta lipoprotein fraction. Acta Med Scand Suppl 1972; 531:1-29.
3. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758-65.
4. Herrmann W, Hanf S, Schmidt H, Kostner GM. Lp(a) - ein besonderes Lipoprotein mit atherogener Wirkung. Z Klin Med 1987; 42:1333-6.
5. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J 1990; 301:1248-51.
6. Wiklund O, Angelin B, Olofsson SO, Eriksson M, Fager G, Berglund L, et al. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia [see comments]. Lancet 1990; 335:1360-3.
7. Kark JD, Sandholzer C, Friedlander Y, Utermann G. Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population. Atherosclerosis 1993; 98:139-51.
8. Wild SH, Fortmann SP, Marcovina SM. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Arterioscler Thromb Vasc Biol 1997; 17: 239-45.
9. Utermann G. The mysteries of lipoprotein(a). Science 1989; 246:904-10.
10. Utermann G, Weber W. Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett 1983; 154:357-61.
11. Eaton DL, Fless GM, Kohr WJ, McLean JW, Xu QT, Miller CG, et al. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA 1987; 84:3224-8.
12. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330: 132-7.
13. Scanu AM. Lp(a) as a marker for coronary heart disease risk. Clin Cardiol 1991; 14:135-9.
14. Marcovina SM, Zhang ZH, Gaur VP, Albers JJ. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun 1993; 191: 1192-6.
15. Sommer A, Gorges R, Kostner GM, Paltauf F, Hermetter A. Sulfhydryl-selective fluorescence labeling of lipoprotein(a) reveals evidence for one single disulfide linkage between apoproteins(a) and B-100. Biochemistry 1991; 30:11245-9.
16. White AL, Rainwater DL, Lanford RE. Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes. J Lipid Res 1993; 34:509-17.
17. Wilkinson J, Munro LH, Higgins JA. Apolipoprotein[a] is not associated with apolipoprotein B in human liver. J Lipid Res 1994; 35:1896-901.
18. Frank S, Durovic S, Kostner GM. Structural requirements of apo-a for the lipoprotein-a assembly. Biochem J 1994; 304:27-30.
19. Ernst A, Helmhold M, Brunner C, Petho SA, Armstrong VW, Muller HJ. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a). J Biol Chem 1995; 270:6227-34.
20. Linton MF, Farese RV Jr, Chiesa G, Grass DS, Chin P, Hammer RE, et al. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest 1993; 92:3029-37.
21. White AL, Lanford RE. Cell surface assembly of lipoprotein(a) in primary cultures of baboon hepatocytes. J Biol Chem 1994; 269:28716-23.
22. Trieu VN, McConathy WJ. A two-step model for lipoprotein(a) formation. J Biol Chem 1995; 270:15471-4.
23. Callow MJ, Rubin EM. Site-specific mutagenesis demonstrates that cysteine 4326 of apolipoprotein B is required for covalent linkage with apolipoprotein(a) in vivo. J Biol Chem 1995; 270:23914-7.
24. McCormick SP, Ng JK, Taylor S, Flynn LM, Hammer RE, Young SG. Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a). Proc Natl Acad Sci USA 1995; 92:10147-51.
25. Guevara J, Valentinova NV, Garcia O, Gotto AM, Yang CY, Legal S, et al. Interaction of apolipoprotein[a] with apolipoproteinB-100 Cys3734 region in lipoprotein[a] is confirmed immunochemically. J Protein Chem 1996; 15:17-25.
26. Phillips ML, Lembertas AV, Schumaker VN, Lawn RM, Shire SJ, Zioncheck TF. Physical properties of recombinant apolipoprotein(a) and its association with LDL to form an Lp(a)-like complex. Biochemistry 1993; 32:3722-8.
27. Trieu VN, Zioncheck TF, Lawn RM, McConathy WJ. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. J Biol Chem 1991; 266:5480-5.
28. Ye SQ, Trieu VN, Stiers DL, McConathy WJ. Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a). J Biol Chem 1988; 263:6337-43.
29. Gries A, Nimpf J, Nimpf M, Wurm H, Kostner GM. Free and apo B-associated Lpa-specific protein in human serum. Clin Chim Acta 1987; 164:93-100.
30. Mooser V, Seabra MC, Abedin M, Landschulz KT, Marcovina S, Hobbs HH. Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a). J Clin Invest 1996; 97:858-64.
31. Mooser V, Marcovina SM, White AL, Hobbs HH. Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine. J Clin Invest 1996; 98:2414-24.
32. Kostner KM, Maurer G, Huber K, Stefenelli T, Dieplinger H, Steyrer E, Kostner GM. Urinary excretion of apo(a) fragments. Role in apo(a) catabolism. Arterioscler Thromb Vasc Biol 1996; 16:905-11.
33. Kostner KM, Huber K, Stefenelli T, Rinner H, Maurer G. Urinary apo(a) discriminates coronary artery disease patients from controls. Atherosclerosis 1997; 129:103-10.
34. 2 and 3,3′,5,5′-tetramethylbenzidine. J Clin Chem Clin Biochem 1985; 23:453-60.
35. Kraft HG, Lingenhel A, Bader G, Kostner GM, Utermann G. The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes. Atherosclerosis 1996; 125:53-61.
36. Lawn RM, Wade DP, Hammer RE, Chiesa G, Verstuyft JG, Rubin EM. Atherogenesis in transgenic mice expressing human apolipoprotein(a) [see comments]. Nature 1992; 360:670-2.
37. Liu AC, Lawn RM, Verstuyft JG, Rubin EM. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice. J Lipid Res 1994; 35:2263-7.
38. Armstrong VW, Harrach B, Robenek H, Helmhold M, Walli AK, Seidel D. Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. J Lipid Res 1990; 31:429-41.
39. Steyrer E, Kostner GM. Interaction of lipoprotein Lp[a] with the B/E-receptor: a study using isolated bovine adrenal cortex and human fibroblast receptors. J Lipid Res 1990; 31:1247-53.
40. Krempler F, Kostner GM, Roscher A, Haslauer F, Bolzano K, Sandhofer F. Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest 1983; 71:1431-41.
41. Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation 1989; 80:1313-9.
42. Kostner GM, Grillhofer HK. Lipoprotein(a) mediates high affinity low density lipoprotein association to receptor negative fibroblasts. J Biol Chem 1991; 266:21287-92.
43. Kostner GM. Interaction of Lp(a) and of apo(a) with liver cells. ArteriosclerThromb 1993; 13:1101-9.
44. Liu R, Saku K, Kostner GM, Hirata K, Zhang B, Shiomi M, et al. In vivo kinetics of lipoprotein(a) in homozygous Watanabe heritable hyperlipidaemic rabbits. Eur J Clin Invest 1993; 23:561-5.
45. Hofmann SL, Eaton DL, Brown MS, McConathy WJ, Goldstein JL, Hammer RE. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest 1990; 85:1542-7.
46. Kostner GM. The physiological role of Lp(a). In: Scanu AM, editor. Lipoprotein(a). San Diego: Academic Press, 1990: 183-204.
47. Oida K, Takai H, Maeda H, Takahashi S, Shimada A, Suzuki J, et al. Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure. Clin Chem 1992; 38:2244-8.
48. März W, Siekmeier R, Gross W, Kostner GM. Determination of lipoprotein(a): evaluation of three methods. Eur J Clin Chem Clin Biochem 1993; 31:295-302.
49. Taddei-Peters WC, Butman BT, Jones GR, Venetta TM, Macomber PF, Ransom JH. Quantification of lipoprotein(a) particles containing various apolipoprotein(a) isoforms by a monoclonal anti-apo(a) capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassay. Clin Chem 1993; 39:1382-9.
50. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem 1995; 41:246-55.